A campaigning doctor in the US has called on insurance companies to cover CBD treatments for patients.
Dr Sanjay Gupta, president of the American Pain Association (APA), said CBD could help with the USA’s opioid crisis by providing an alternative treatment widely considered not to be habit-forming or addictive.
“Given the choice between Oxycontin, Percocet and CBD, patients are more likely to choose the narcotics because they are covered by insurance companies and are affordable with co-pays or even free of charge,” Gupta said. “Insurance companies should be open to paying for patients who are willing to reduce opioid use by using CBD.”
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.